Skip to main content
Premium Trial:

Request an Annual Quote

Gates Foundation Awards Opko $1M for TB MDx Development

NEW YORK (GenomeWeb News) – Opko Health has received a $1 million grant from the Bill and Melinda Gates Foundation for the development of a tuberculosis test, the company announced today.

The grant will support development of a test for distinguishing latent TB from active TB using Opko's molecular diagnostics technology. The Miami-based firm also leverages the technology to create blood-based tests for identifying biomarkers for diseases including neurodegenerative disorders and malignancies.

Opko is a pharmaceutical and diagnostic firm. Its molecular diagnostics platform was developed in the laboratory of Thomas Kodadek at the Scripps Research Institute and is based on immunoglobulin autoantibodies as disease-specific biomarkers, the company said on its website.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.